Nitzan Rosenfeld receives Translational Research Award
Congratulations to Nitzan Rosenfeld, who has won the 2013 British Association for Cancer Research Translational Research Award.
The purpose of the award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory – clinic) cancer research.
The lab are working on developing effective methods to make use of circulating tumour DNA (ctDNA), which is found in blood and other body fluids and contains much useful information about a patient’s cancer. For example, by using genomic techniques to study ctDNA researchers can learn about the evolution of a patient’s tumour and how it is developing resistance to therapy. The advantage of using ctDNA to diagnose and monitor disease is that it can be collected relatively non-invasively, through a blood test rather than a tumour biopsy, and ease of sample collection means that you can take many more samples to follow the development and changes in a tumour.
Related News
See all news-
Institute scientists uncover molecular switch that drives pancreatic cancer progression
30th October 2025
New research from our Carroll Group has identified a molecular mechanism that helps explain how pancreatic ductal adenocarcinoma progresses, offering a potential path toward more targeted treatments.
Find out more -
Scientists to Shine a Light on Cancer Research at Inspirational Night Walk
10th October 2025
Dr Shalini Rao, a Senior Research Associate at the Cancer Research UK Cambridge Institute, will join postgraduate students Marleen Wolke and Josephine Greenall-Ota for the Shine Night Walk on Saturday, 18 October.
Find out more -
Prof Greg Hannon shortlisted for prestigious Cancer Grand Challenge
24th September 2025
The shortlist of 12 multidisciplinary, global teams is now competing for up to £20m each, with the aim of delivering breakthroughs that no single researcher, lab, institute or country could achieve alone.
Find out more